Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enteral Naloxone for Opioid-Induced Constipation in Trauma Patients
NCT00799201Phase 4Terminated
- Sponsor
- CAMC Health System
- Start
- Aug 2007
- Primary completion
- Oct 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of naloxone in opioid-induced constipation (OIC), gastroparesis, sponsored by CAMC Health System. Started Aug 2007; status: terminated.
02
Drugs
naloxone
03
Conditions
opioid-induced constipation (OIC)gastroparesis
Beyond the preview
Go deeper on NCT00799201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799201.